 |
|
|
 Hot Stock to Watch |
Company: Terra Tech Corp (OTCQB: TRTC)
|
Last:
Price: 1.04
Change (%): + 0.165 (18.86)
Volume: 7,144,624 |
 |
Terra Tech Corp Expands Into CBD and Botanical Extraction
Oakland, March 24, 2014 (GLOBE NEWSWIRE) - Terra Tech Corp. (TRTC), through their medical cannabis subsidiary GrowOp Technology Ltd, is pleased to announce they are developing a research and industrial extraction facility focused on the medical cannabis market. The facility will be located in Oakland, CA and is being built in response to what the company views as an increase in demand for high grade CBD as well as other botanical extracts. As a first step the company has purchased a custom 20 liter 5,000 PSI supercritical CO2 extractor from Eden Labs.
The extractor is designed for botanical and nutraceutical extractions and will be utilized to extract CBD in an effort to have complete control and consistency as they continue to work with Inergetics in the creation of a CBD-based nutritional supplement. This key piece of equipment utilizes CO2 as a solvent, which is superior because it is non-flammable and non-toxic mitigating negative environmental impacts as well as several safety concerns that have been associated with butane extraction. This process allows for the selective extraction of compounds from a variety of botanicals, which possess potent antioxidant as well as neuroprotectant properties.
“Consumers are becoming more educated about safety and quality as the legal medical cannabis market spreads throughout the US,” explains Derek Peterson, CEO of Terra Tech Corp. “Patients deserve access to products that are both effective and free from harmful residues. Our intention once we complete our top of the line facility is to partner with a permitted California based medical cannabis dispensary where we can pair their expertise with our equipment and technology to synthesize and create some amazing products.”
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
